[go: up one dir, main page]

WO2002011549A3 - Treatment of mycobacterial infection - Google Patents

Treatment of mycobacterial infection Download PDF

Info

Publication number
WO2002011549A3
WO2002011549A3 PCT/GB2001/003625 GB0103625W WO0211549A3 WO 2002011549 A3 WO2002011549 A3 WO 2002011549A3 GB 0103625 W GB0103625 W GB 0103625W WO 0211549 A3 WO0211549 A3 WO 0211549A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
methods
mycobacterial infection
humans
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/003625
Other languages
French (fr)
Other versions
WO2002011549A2 (en
Inventor
Vladimir Di Pasechnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
POLYANSKAYA NATASHA HF
REGMA BIO TECHNOLOGIES Ltd NEVADA USA
REGMA BIO TECHNOLOGIES Ltd NEV
Original Assignee
POLYANSKAYA NATASHA HF
REGMA BIO TECHNOLOGIES Ltd NEVADA USA
REGMA BIO TECHNOLOGIES Ltd NEV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by POLYANSKAYA NATASHA HF, REGMA BIO TECHNOLOGIES Ltd NEVADA USA, REGMA BIO TECHNOLOGIES Ltd NEV filed Critical POLYANSKAYA NATASHA HF
Priority to AU2001282277A priority Critical patent/AU2001282277A1/en
Publication of WO2002011549A2 publication Critical patent/WO2002011549A2/en
Publication of WO2002011549A3 publication Critical patent/WO2002011549A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/10—Preservation of milk or milk preparations
    • A23B11/18—Preservation of milk or milk preparations by addition of preservatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K30/00—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
    • A23K30/10—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
    • A23K30/15—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging
    • A23K30/18—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to methods for the reduction of diseases caused by mycobacteria in animals and humans, methods for curbing the spread of such diseases from one animal infected with said mycobacteria to other animals or to humans, methods for the treatment of consumables for humans and animals, and preparations and kits for use in such methods.
PCT/GB2001/003625 2000-08-10 2001-08-10 Treatment of mycobacterial infection Ceased WO2002011549A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001282277A AU2001282277A1 (en) 2000-08-10 2001-08-10 Treatment of mycobacterial infection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0019721.0 2000-08-10
GBGB0019721.0A GB0019721D0 (en) 2000-08-10 2000-08-10 Novel method

Publications (2)

Publication Number Publication Date
WO2002011549A2 WO2002011549A2 (en) 2002-02-14
WO2002011549A3 true WO2002011549A3 (en) 2002-08-22

Family

ID=9897393

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/003625 Ceased WO2002011549A2 (en) 2000-08-10 2001-08-10 Treatment of mycobacterial infection

Country Status (3)

Country Link
AU (1) AU2001282277A1 (en)
GB (1) GB0019721D0 (en)
WO (1) WO2002011549A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2799063A1 (en) * 2013-04-30 2014-11-05 Ferring B.V. Bacteriophage therapy
CN108126190B (en) * 2017-11-02 2021-01-26 重庆医科大学附属第一医院 Preparation and application of mycobacterium phage lyase Lysin-Guo1
WO2020061002A1 (en) * 2018-09-18 2020-03-26 Map/Path Llc Methods and composition for controlling map infection and contamination
CN115902217B (en) * 2023-03-08 2023-06-16 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） Indirect ELISA (enzyme-Linked immuno sorbent assay) detection kit for bovine paratuberculosis and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022713A1 (en) * 1995-12-15 1997-06-26 Biotec Laboratories Limited Method to detect bacteria
WO1999057304A1 (en) * 1998-05-02 1999-11-11 Scottish Crop Research Institute Bacteriophage assay
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022713A1 (en) * 1995-12-15 1997-06-26 Biotec Laboratories Limited Method to detect bacteria
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
WO1999057304A1 (en) * 1998-05-02 1999-11-11 Scottish Crop Research Institute Bacteriophage assay

Also Published As

Publication number Publication date
WO2002011549A2 (en) 2002-02-14
AU2001282277A1 (en) 2002-02-18
GB0019721D0 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
DK1212422T3 (en) Human CTLA-4 antibodies and their uses
WO1999052515A3 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
NO20041882L (en) Methods for the treatment of ocular neovascular diseases.
DE60137631D1 (en) IREOVIRUS ANTIBODIES FOR THE TREATMENT OF RAS-MEDIATED, PROLIFERATIVE DISEASES
WO2006078287A3 (en) Pde4b inhibitors and uses therefor
BR0309095A (en) Use of osteoprotegerin for the treatment and / or prevention of fibrotic disease.
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
BRPI0407662B8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
ATE335499T1 (en) COMPOSITIONS FOR THE TREATMENT OF STAPHYLOCOCCUS AUREUS INFECTIONS
DE60236318D1 (en) PREPARATIONS OF GRAMPOSITIVE BACTERIA FOR THE TREATMENT OF DISEASES WITH IMMUNE RADIATION
WO2006002437A3 (en) Treatment of conditions involving demyelination
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
DE60016047D1 (en) DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide
BR0307085A (en) Combination therapy for the treatment of bacterial infections
WO2002011549A3 (en) Treatment of mycobacterial infection
AU2003272189A1 (en) Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
WO2001044235A3 (en) Agents and methods for the treatment of proliferative diseases
DE60124093D1 (en) S-methyl-dihydro-ziprasidone for the treatment of eye diseases.
DE69935662D1 (en) MEANS FOR THE PREVENTION / TREATMENT OF INFLAMMATORY ENDURANCE
WO2001072334A3 (en) Methods for treating disease with antibodies to cxcr3
ATE364625T1 (en) PROTEINS FROM YABA MONKEY TUMOR VIRUS WITH MODULATORY ACTIVITY
WO2000041526A3 (en) Use of s-triazines for treating apicomplexan parasitic infections
WO2005023288A8 (en) Treatment of fibrotic disease
WO2003096987A9 (en) Methods of use and compositions for the diagnosis and treatment of infectious disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP